[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-355908-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-355908-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","burden-and-trends-of-genitourinary-cancers-across-the-americas-a-gbd-2023-analysis-of-regional-socioeconomic-gradients","Burden and Trends of Genitourinary Cancers Across the Americas - A GBD 2023 Analysis of Regional Socioeconomic Gradients","","Genitourinary cancers are a major and growing cancer burden across the Americas, yet incidence, mortality, and disability are unevenly distributed. Using Global Burden of Disease 2023 estimates for 38 countries and territories from 2000 to 2023, the study analyzes age-standardized incidence, mortality, and DALY rates, and evaluates temporal changes with weighted log-linear regression. Results identify persistent and widening inequalities, with greatest overall burden in 2023 from prostate cancer and elevated mortality and DALYs concentrated in Latin America and the Caribbean.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/burden-and-trends-of-genitourinary-cancers-across-the-americas-a-gbd-2023-analysis-of-regional-socioeconomic-gradients/355908/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/burden-and-trends-of-genitourinary-cancers-across-the-americas-a-gbd-2023-analysis-of-regional-socioeconomic-gradients/355908.png","ImageObject",300,407,{"name":42,"@type":43},"Jasmine","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-07","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What data and time period were used to study genitourinary cancer trends?","Question",{"text":63,"@type":64},"The analysis used Global Burden of Disease (GBD) 2023 estimates for 38 countries and territories, covering 2000 to 2023.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which outcomes were analyzed across the cancer types?",{"text":68,"@type":64},"Age-standardized incidence, mortality, and disability-adjusted life year (DALY) rates per 100,000 population were assessed for prostate, bladder, kidney, and testicular cancers.",{"name":70,"@type":61,"acceptedAnswer":71},"What geographic disparities were highlighted in 2023 results?",{"text":72,"@type":64},"Prostate cancer contributed the largest overall burden in 2023, with high incidence concentrated in high-income North America, while mortality and DALY rates were disproportionately elevated in Latin America and the Caribbean.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},355908,1790376188,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336478487870,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Article  \nBurden and Trends of Genitourinary Cancers Across the Americas: A GBD 2023 Analysis of Regional  \nSocioeconomic Gradients  \nJosé Guzmán-Esquivel 1, Gustavo A. Hernández-Fuentes 2,3,4, Kayim Pineda-Urbina 4,  \nJanet Diaz-Martinez 5,6, Carlos M. Hernandez-Suarez 7, Jesús Venegas-Ramírez 8, Gabriel Ceja-Espíritu 2, Iram P. Rodríguez-Sánchez 9, Margarita L. Martinez-Fierro 10, Idalia Garza-Veloz 10, Fabian Rojas-Larios 2, Alejandrina Rodríguez-Hernandez 2, Daniel A. Montes-Galindo 4 and Iván Delgado-Enciso 2,3,6, *  \nAcademic Editors: Ilir Agalliu and Evan Kovac  \nReceived: 19 May 2026  \nRevised: 14 June 2026  \nAccepted: 16 June 2026  \nPublished: 22 June 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Clinical Epidemiology Research Unit, Mexican Institute of Social Security (IMSS), Villa de Alvarez 29883, Colima, Mexico; [jose.esquivel@imss.gob.mx](jose.esquivel@imss.gob.mx)  \n2 Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico; [ghfuentes@ucol.mx](ghfuentes@ucol.mx) (G.A.H.-F.); [gcejae11@ucol.mx](gcejae11@ucol.mx) (G.C.-E.); [frojas@ucol.mx](frojas@ucol.mx) (F.R.-L.); [arodrig@ucol.mx](arodrig@ucol.mx) (A.R.-H.)  \n3 State Cancerology Institute of Colima, Health Services of the Mexican Social Security Institute for Welfare (IMSS-BIENESTAR), Colima 28085, Mexico  \n4 Faculty of Chemical Sciences, University of Colima, Coquimatlan 28400, Mexico; [kpineda@ucol.mx](kpineda@ucol.mx) (K.P.-U.); [daniel_montes@ucol.mx](daniel_montes@ucol.mx) (D.A.M.-G.)  \n5 Research Center in Minority Institutions, Florida International University (FIU-RCMI), Miami, FL 33199, USA; [jdimarti@fiu.edu](jdimarti@fiu.edu)  \n6 Department of Dietetics & Nutrition, Robert Stempel College of Public Health & Social Work, Florida International University (FIU-RCMI), Miami, FL 33199, USA  \n7 Coordinación General de Investigación, University of Colima, Colima 28040, Mexico; [cmh1@cornell.edu](cmh1@cornell.edu)  \n[8](8 Department of Nephrology)[ Department of Nephrology](8 Department of Nephrology), [Instituto Mexicano del Seguro Social](Instituto Mexicano del Seguro Social) ([IMSS](IMSS)), Hospital de Zona No. 1, Villa de Álvarez 28984, Colima, Mexico; [jesus.venegas@imss.gob.mx](jesus.venegas@imss.gob.mx)  \n9 Molecular and Structural Physiology Laboratory, School of Biological Sciences, Universidad Autónoma de Nuevo León, San Nicolás de los Garza 66455, Nuevo León, Mexico; [iram.rodriguezsa@uanl.edu.mx](iram.rodriguezsa@uanl.edu.mx)  \n10 Molecular Medicine Laboratory, Academic Unit of Human Medicine and Health Sciences, Autonomous University of Zacatecas, Zacatecas 98160, Mexico; [margaritamf@uaz.edu.mx](margaritamf@uaz.edu.mx) (M.L.M.-F.); [idaliagv@uaz.edu.mx](idaliagv@uaz.edu.mx) (I.G.-V.)  \n* Correspondence: [ivan_delgado_enciso@ucol.mx; Tel./Fax: +52-312-3161099](ivan_delgado_enciso@ucol.mx; Tel./Fax: +52-312-3161099)  \nSimple Summary  \nGenitourinary cancers, including prostate, bladder, kidney, and testicular cancers, are an increasing public health challenge across the Americas. However, the burden of these malignancies is not evenly distributed. Countries with higher socioeconomic development tend to report more diagnosed cases, which may reflect greater access to screening and diagnostic technologies, while lower-resource settings experience disproportionately higher mortality and disability. Using data from the Global Burden of Disease 2023 study, we evaluated long-term trends in incidence, mortality, and disability-adjusted life years across 38 countries and territories from 2000 to 2023 . Our findings reveal persistent and widening inequalities, particularly in Latin America and the Caribbean, which may reflect differences in healthcare resources and cancer care delivery. These findings support the need to evaluate strategies aimed at","cbCaicVCkc7eHOgV","https://ap.wps.com/l/cbCaicVCkc7eHOgV","pdf",1324757,26,"English","# Simple Summary\n# Abstract\n## Background/Objectives\n## Methods\n## Results","[{\"question\":\"What data and time period were used to study genitourinary cancer trends?\",\"answer\":\"The analysis used Global Burden of Disease (GBD) 2023 estimates for 38 countries and territories, covering 2000 to 2023.\"},{\"question\":\"Which outcomes were analyzed across the cancer types?\",\"answer\":\"Age-standardized incidence, mortality, and disability-adjusted life year (DALY) rates per 100,000 population were assessed for prostate, bladder, kidney, and testicular cancers.\"},{\"question\":\"What geographic disparities were highlighted in 2023 results?\",\"answer\":\"Prostate cancer contributed the largest overall burden in 2023, with high incidence concentrated in high-income North America, while mortality and DALY rates were disproportionately elevated in Latin America and the Caribbean.\"}]","Burden and Trends of Genitourinary Cancers Across the Americas - A GBD 2023 Analysis of Regional Socioeconomic Gradients | PDF",1790121685,66,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eebbb2ab506973f2cee7ee29ab4003df.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/46fec5a1ed201a4bb03523b01c444c0c.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/da6ef3b965f01c5e68aac08448a19dfd.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c8f5fd6a05391f50c6cf23bce27d834e.webp",980,1385]